Symbols

PTE(Delisted)

PolarityTE·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PTE

Polarityte, Inc.

A biotech company that develops regenerative tissue products and biomaterials

Industry

Established Date

Listing Date

01/26/2005

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.polarityte.com

Security Type

Common stock

Office address

1960 S. 4250 West, Salt Lake City, Utah 84104

Business

Introduction

PolarityTE, Inc., was incorporated in 1986 under the laws of the State of New Jersey. The company is a biotechnology company developing regenerative tissue products and biomaterials. The company also operates laboratory testing and clinical research businesses with the equipment, personnel and facilities they acquire to advance the development of its regenerative tissue products. The company's first regenerative tissue product is SkinTE, which is designed to repair, rebuild, replace and replenish the skin of patients who need to treat acute or chronic wounds, burns, surgical reconstruction events, scar repair.

Company Financials

EPS

PTE has released its 2022 Q4 earnings. EPS was reported at -0.13, versus the expected 0, missing expectations. The chart below visualizes how PTE has performed over recent quarters, highlighting trends in earnings surprises.